Eisai Oncology to Present New Research on Product Portfolio, Pipeline at ASCO Annual Meeting

Eisai Oncology to Present New Research on Product Portfolio, Pipeline at ASCO Annual Meeting
WOODCLIFF LAKE, N.J.—-Eisai announced today that 15 abstracts highlighting new study results on metastatic breast cancer, ovarian cancer, non-small cell lung cancer, metastatic brain cancer, peripheral T-cell lymphoma and other cancers will be presented during the 46th Annual Meeting of the American Society of Clinical Oncology , taking place in Chicago from June 4 to June 8, 2010.

Read more on Business Wire via Yahoo! Finance

More Meth Drug Addiction Info:

• Information on Types and Treatment of Lung Cancer | Thaipparambil.com
• Primary cutaneous peripheral T–cell lymphoma, unspecified with an …
• What Is Lung Cancer? | Mesothelioma & Lung Cancer Information
• Ramsey, N.J. office to relocate to new Woodcliff Lake location …
• The Science and Technology Blog » Blog Archive » NYU Cancer …
• ASCO Releases Studies From Upcoming 2010 Annual Meeting « Libby's …
• Dendreon Announces Presentation of PROVENGE Data at the American …
• Necessary Steps for Lung Cancer Prevention | Mesothelioma Treatment
• Amgen Highlights Key Clinical Data To Be Presented At American …
• Active Biotech's TASQ Prostate Cancer Project To Be Presented At …